53-Year-Old Soviet Spacecraft to Perform 'Final Death Plunge'
After decades of inadvertently orbiting Earth, Kosmos 482 is ready to come home. Astronomers believe the Soviet-era spacecraft is ready to perform its "final death plunge," which will most likely occur this weekend. Kosmos 482 will either disintegrate upon atmospheric reentry or smack into Earth's surface—and one renowned astrophysicist is anticipating the latter.
The Soviet Union launched Kosmos 482 on March 31, 1972. At the time, the spacecraft was part of the Venera program, which aimed to place multiple probes in Venus's atmosphere and on its surface. While many Venera probes succeeded, the one launched that day did not: Its escape stage exploded as it attempted to achieve a Venus transfer trajectory, causing the spacecraft to break apart. Some of its fragments decayed within 48 hours, causing space debris to fall onto New Zealand. But the lander probe survived.
Back then, it was tradition to attach "Kosmos" to the name of any Soviet spacecraft that achieved Earth orbit, accidentally or not; as a result, the failed Venera probe became Kosmos 482. It's circled our planet ever since, starting as high as 6,000 miles and gradually sinking down to its current maximum of 245 miles above Earth's surface. Now, the 1,092-pound hunk of metal is preparing to re-enter the planet's atmosphere, according to computer models tracking Kosmos 482's slow descent.
"It's in its final death plunge," Jonathan McDowell, an astronomer at the Harvard & Smithsonian Center for Astrophysics, said on NPR's All Things Considered.
The meter-wide Kosmos 482 lander probe. Credit: NASA
McDowell tracks satellite and space debris, sharing the juiciest of his findings via social media. Many times, these objects aerosolize upon reentry; on occasion, they survive the trip. Since Kosmos 482 was originally designed to withstand Venus's atmosphere, McDowell thinks this particular spacecraft could be a survivor.
"What I expect is instead of burning up and melting, it will reenter essentially undamaged," McDowell told NPR. "And so somewhere on Earth, this half ton sphere will fall out of the sky at a couple hundred miles an hour. And most likely it'll be over the ocean, and no one will ever know….There's a not trivial chance that it could hit somewhere where it damages property. And there's a small chance—but it's like one in thousands—that it could hurt somebody."
Marco Langbroek, a spy satellite researcher at the Dutch satellite tracking station SatTrackCam Leiden, co-developed a reentry model that places Kosmos 482's potential landing anywhere between Canada, Russia, and the southern end of South America—a vast swath of Earth that doesn't afford many global citizens much comfort. But even this blurry geographical window might not be accurate.
"The reentry is an uncontrolled reentry," Langbroek notes. "At the moment, we cannot say with any degree of certainty when and where the Kosmos 482 Descent Craft exactly will reenter."
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
38 minutes ago
- Yahoo
Sobi Showcases Breadth of data in C3G/primary IC-MPGN at ERA 2025
STOCKHOLM, June 4, 2025 /PRNewswire/ -- Sobi® (STO: SOBI) will have a strong scientific presence at this year's ERA congress in Vienna (4-7 June) with a total of eight presentations: six oral presentations and two posters. We are proud that two of our abstracts have been recognised in the top 10 abstracts at ERA 2025, as selected by expert reviewers coordinated by the ERA Paper Selection Committee. Notably, 52-week results from the open-label-period (OLP) of the VALIANT Phase 3 study will be presented for the first time. This data will be featured in an oral presentation by Professor Fadi Fakhouri (Lausanne University Hospital and University of Lausanne) during the session "Innovative Kidney Trials", on 6 June 2025 at 15:00 CEST. The two abstracts selected in the top 10 at the conference both highlight important subgroup results from the randomised-controlled-period (RCP) of the VALIANT Phase 3 study covering the treatment effect of pegcetacoplan at 26 weeks in patients with nephrotic range proteinuria at baseline, and the effect of pegcetacoplan in adolescents at 26 weeks. Lydia Abad-Franch, MD, MBA, Head of Research, Development, and Medical Affairs (RDMA), and Chief Medical Officer at Sobi says, "The large number of oral presentations, including one achieving the highest ranking of all ERA abstracts and a second in the top 10, reflects the importance of the data and research outputs being generated from our work aimed at advancing treatments for rare kidney conditions." Key data to be presented at ERA 2025 VALIANT A thematic analysis of healthcare provider perspective on the care pathway and unmet needs in patients with C3 glomerulopathy (C3G) and primary immune complex membranoproliferative glomerulonephritis (IC-MPGN) in the US and Europe. Presenter: Carly Rich Poster presentation Session: Glomerular & tubulo-interstitial diseases Room: XWall 1 Mozart Symphony No. 40 Date: 5 June 2025 Time: 13:12 CEST Pegcetacoplan treatment effect in patients with nephrotic range proteinuria: results from the VALIANT Phase 3 study in patients with C3G or Primary (Idiopathic) IC-MPGN Presenter: Antonio Mastrangelo Oral presentation Session: FC 14: About C3 and IgA Glomerulonephritis Room: Hall F1 Date: 6 June 2025 Time: 08:15 CEST Targeted treatment with pegcetacoplan for adolescents with C3G or Primary (Idiopathic) IC- MPGN in the VALIANT Phase 3 trial Presenter: Antonio Mastrangelo Oral presentation Session: FC 14: About C3 and IgA Glomerulonephritis Room: Hall F1 Date: 6 June 2025 Time: 08:30 CEST Pegcetacoplan demonstrates clinically significant responses in C3G and Primary (Idiopathic) IC-MPGN patients with or without concomitant immunosuppression in VALIANT Presenter: David Kavanagh Oral presentation Session: FC 14: About C3 and IgA Glomerulonephritis Room: Hall F1 Date: 6 June 2025 Time: 09:30 CEST Association between proteinuria and clinically meaningful endpoints in patients with C3G / IC- MPGN: a Delphi consensus of European experts Presenter: Fernando Caravaca-Fontán Poster Presentation Session: Chronic Kidney Disease Room: Strauss Wiener Blut Date: 6 June 2025 Time: 13:06 CEST Pegcetacoplan for C3G and primary (idiopathic) IC- MPGN: 52-week results from the phase 3 VALIANT trial show sustained efficacy Presenter: Fadi Fakhouri Oral presentation Session: Innovative Kidney Trials Room: The Square Date: 6 June 2025 Time: 15:00 CEST Targeted Treatment with Pegcetacoplan for post- Transplant Recurrent C3G or Primary (idiopathic) IC-MPGN in the VALIANT Phase 3 Trial Presenter: Michiel Oosterveld Focused Oral presentation Session: Glomerular & tubulo-interstitial diseases Room: Focused Oral Room 3 Date: 6 June 2025 Time: 15:54 CEST Pegcetacoplan Treatment appears to halt disease progression in C3G and Primary (Idiopathic) IC-MPGN patients: results from the Phase 3 VALIANT study Presenter: Daniel Gale Focused Oral presentation Session: Glomerular & tubulo-interstitial diseases Room: Focused Oral Room 3 Date: 6 June 2025 Time: 16:06 CEST About the VALIANT Study The VALIANT Phase 3 study (NCT05067127) was a randomised, placebo-controlled, double-blinded, multi-centre study evaluating pegcetacoplan efficacy and safety in 124 patients who were 12 years of age and older, with C3G or primary IC-MPGN. It is the largest single trial conducted in these populations and the only study to include adolescent and adult patients, with native and post-transplant kidneys. During the 26-week randomised-controlled-period (RCP) of VALIANT, patients received twice weekly subcutaneous pegcetacoplan or placebo. The RCP was followed by a 26-week open-label period (OLP) in which all patients received pegcetacoplan. The primary endpoint of the study was the log transformed ratio of urine protein-to-creatinine ratio (UPCR) at week 26 compared to baseline. About Sobi Sobi is a global biopharma company unlocking the potential of breakthrough innovations, transforming everyday life for people living with rare diseases. Sobi has approximately 1,900 employees across Europe, North America, the Middle East, Asia and Australia. In 2024, revenue amounted to SEK 26 billion. Sobi's share (STO:SOBI) is listed on Nasdaq Stockholm. More about Sobi at and LinkedIn, BlueSkyX Contacts For details on how to contact the Sobi Investor Relations Team, please click here. For Sobi Media contacts, click here. This information was brought to you by Cision The following files are available for download: Sobi Showcases Breadth of data at ERA 2025 View original content: Sign in to access your portfolio
Yahoo
6 hours ago
- Yahoo
Trump withdraws nominee to lead NASA Jared Isaacman, a close ally of Elon Musk
WASHINGTON ― President Donald Trump has pulled his nomination of Jared Isaacman, a billionaire commercial astronaut with close ties to Elon Musk, as his nominee to serve as administrator of NASA. The White House confirmed the withdrawal on May 31 and said Trump will soon announce a new nominee to lead NASA. No reason was provided for parting ways with Isaacman, who led and financed private astronaut missions Polaris Dawn and Inspiration4, which was carried out by Musk's SpaceX. The withdrawal, first reported by the news website Semafor, comes after the 42-year-old Isaacman already cleared the Senate Commerce Committee in April and appeared on track for a full Senate vote. 'The Administrator of NASA will help lead humanity into space and execute President Trump's bold mission of planting the American flag on the planet Mars," White House Assistant Press Secretary Liz Huston said in a statement. "It's essential that the next leader of NASA is in complete alignment with President Trump's America First agenda, and a replacement will be announced directly by President Trump soon." More: Elon Musk's rise and fall: From Trump's chainsaw-wielding sidekick to a swift exit The move comes a day after Musk, a business partner and friend of Isaacman, left the White House after spending four months as a senior White House adviser overseeing the Department of Government Efficiency. Musk joined Trump for an Oval Office news conference to mark the end of the billionaire Tesla and SpaceX CEO's tenure in the White House. "It is rare to find someone so competent and good-hearted," Musk said in a post on X, in reaction to Trump's decision to withdraw Isaacman's nomination. Conservative activist Laura Loomer, who has proven influential in many Trump decisions, raised alarm about the status of Isaacman's nomination in an X post, hours before the White House confirmed it was being withdrawn, writing, "There is reason to believe that Isaacman may be facing retaliation because of his friendship with Musk." More: Trump's pick to head NASA has been to space twice: Recapping billionaire's missions Isaacman, founder and CEO of the payment processing company Shift4 Payments, undertook his first private space venture in 2021, when he was commander and financier of the world's first all-civilian extended mission to space. In 2024, he returned to space with an all-civilian crew of amateur spacefarers with the Polaris Dawn mission, which he jointly funded with SpaceX. Isaacman drew concern from some lawmakers over his ties to Musk and SpaceX. During his Senate confirmation hearing in April, he sought to balance NASA's existing moon-aligned space exploration strategy with the Trump administration's push for a space mission to Mars, saying the U.S. can plan for travel to both destinations. As a potential leader of NASA's some 18,000 employees, Isaacman faced a daunting task of implementing that decision to prioritize Mars, given that NASA has spent years and billions of dollars trying to return its astronauts to the moon. NASA, which has about 18,000 employees, has lacked a full-time administrator since Bill Nelson, NASA administrator in the Biden administration, stepped down on Jan. 20 when Trump was inaugurated. Contributing: Eric Lagatta of USA TODAY and Reuters Reach Joey Garrison @joeygarrison. This article originally appeared on USA TODAY: President Trump withdraws nominee to lead NASA Jared Isaacman
Yahoo
6 hours ago
- Yahoo
Dozens of NASA space missions could be axed under Trump's budget: Here's a look at 6
Dozens of NASA's missions to explore the cosmos could be in jeopardy under a budget proposal from the White House. President Donald Trump's administration, which released an initial budget proposal May 2 for the U.S. space agency, dropped more details Friday, May 30 about just which NASA programs it looks to cancel. All told, the budget request for the next fiscal year proposes slashing NASA funding by nearly 25% – from $24.8 billion to $18.8 billion – mostly by eliminating a significant portion of the agency's science portfolio. Trump's proposal, which would need congressional approval, has been lauded by acting NASA Administrator Janet Petro for "still prioritizing critical science and technology research," she said in a statement. But in its own statement, the Planetary Society called the proposed budget "an extinction-level event for the space agency's most productive, successful, and broadly supported activity: science." A total of 41 science projects would get the ax under the proposal, which would be NASA's biggest single-year cut in the agency's history, according to the Planetary Society, a nonprofit space exploration advocacy organization. Many of the science missions Trump looks to cancel are still in development, while others are extended operations with uncrewed vehicles already deployed to orbit. Here's a look at six different types of space missions, from Mars exploration to future moon landings, that could be under threat if Trump's budget were to go into effect. For years, NASA's Mars Sample Return mission has sought to bring back a collection of rocks that could reveal details about potential past life on the Red Planet. The agency's Perseverance rover has been scooping up and storing intriguing rock samples since it first landed in 2021 in the Jezero Crater. But ballooning costs and mission delays have hampered both NASA and the European Space Agency in executing a plan to actually retrieve and transport the samples to Earth for scientists to study further. Meanwhile, Mars Odyssey and MAVEN are two spacecrafts that have been orbiting Mars for years. While those missions could be eliminated, Trump looks to inject another $1 billion to tap the private sector to help lay the groundwork for future Mars exploration. That includes establishing a new NASA initiative called the Commercial Mars Payload Services Program (CMPS). The program would operate similar to NASA's Commercial Lunar Payload Services program by awarding contracts to private companies that would develop spacesuits, vehicles and other technology aimed at reaching the Red Planet. The New Horizons spacecraft became the first spacecraft to explore Pluto up close when it flew by the dwarf planet and its moons on July 14, 2015. In 2019, the space probe reached the Kuiper belt – a doughnut-shaped region of icy bodies extending far beyond the orbit of Neptune – where it continues to make discoveries about the outer solar system. The Juno probe, meanwhile, continues to reveal new insights into the gas giant Jupiter and its Jovian moons nine years after arriving in 2016. The spacecraft recently relayed data unmasking the harsh environments of both Jupiter and its volcanic moon Io. NASA's Space Launch System rocket and Orion space capsule – both seen as centerpieces in the effort to return Americans to the moon – may have their days numbered. The SLS and Orion, which have both launched just once on an uncrewed mission in 2022 from the Kennedy Space Center in Cape Canaveral, Florida, are due to play a role in NASA's lunar ambitions under the Artemis campaign. But Trump seeks to phase out both the SLS and the Orion after just two more missions. That means Artemis II astronauts would still ride an Orion capsule around the moon following liftoff using the SLS rocket as early as 2026. NASA's plans also call for Artemis III astronauts aboard the Orion capsule to board a SpaceX Starship while in orbit for a ride to the moon's surface as early as 2027. Four years ago, NASA selected two missions to Venus under its Discovery program, focused on developing spaceflights to study our solar system. DAVINCI is a planned mission managed by the Goddard Space Flight Center in Maryland for an orbiter and atmospheric descent probe to reach Venus. Its counterpart, VERITAS, is another upcoming mission to map the surface of the planet in high resolution that would be managed from NASA's Jet Propulsion Laboratory in California. Both spacecraft would have been the first NASA vehicles to explore Venus since the 1990s. NASA's OSIRIS-REx, which gathered and returned a sample of asteroid Bennu in September 2023, had been renamed OSIRIS-APophis EXplorer (OSIRIS-APEX) and sent on a path that would allow it to meet up with an infamous asteroid in 2029. That asteroid is name Apophis, and it initially posed a sizable threat to Earth when it was first discovered in 2004 before scientists eventually calculated that its trajectory was harmless. OSIRIS-APEX was meant to spend 18 months mapping the asteroid's surface and analyzing its chemical makeup during a rendezvous with Apophis in June 2029 after the asteroid has a close encounter with Earth. Scientists had considered the mission an invaluable endeavor to allow NASA and other space agency's to build up planetary defense capabilities if a space rock ever posed a threat. The Chandra X-ray Observatory has spent more than 25 years detecting exotic environments in the cosmos to help astronomers understand the structure and evolution of the universe. The space telescope, which launched in 1999 aboard the Space Shuttle Columbia, continues to provide data allowing scientists to make new cosmic discoveries. While the observatory is targeted under Trump's budget proposal, other famous space telescopes like Hubble and the James Webb Space Telescope would remain in operation. Contributing: Brooke Edwards, Rick Neale, USA TODAY Network Eric Lagatta is the Space Connect reporter for the USA TODAY Network. Reach him at elagatta@ This article originally appeared on USA TODAY: Trump's budget targets dozens of NASA space missions: Here's a look